Your session is about to expire
← Back to Search
Fluid Intake App for Obesity
N/A
Waitlist Available
Led By Michael Rocco, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Access to a smartphone for use of the app and comfort with using apps on a regular basis
Access to a smartphone running under either iOS or Android operating systems
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
Study Summary
This trial is designed to test the safety and efficacy of an app that would help hemodialysis patients track their fluid intake to help prevent interdialytic weight gain.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You need to have a smartphone and be comfortable using apps regularly.
Select...
You have a smartphone that runs on either iOS or Android operating systems.
Select...
You are able to understand and use the fluid management app.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Amount of fluid consumed
Amount of interdialytic weight gain
Secondary outcome measures
Number of days that the app was used
Number of days that the app was used by day of the week
Number of days that the app was used by dialysis or non-dialysis days
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: VanguardExperimental Treatment2 Interventions
Participants in this arm will use the fluid intake app and take a survey to test the fluid intake monitoring app for both safety and design issues.
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,230 Previous Clinical Trials
1,001,725 Total Patients Enrolled
38 Trials studying Obesity
5,747 Patients Enrolled for Obesity
Danone ResearchIndustry Sponsor
53 Previous Clinical Trials
13,440 Total Patients Enrolled
Michael Rocco, MDPrincipal InvestigatorWake Forest University Health Sciences
2 Previous Clinical Trials
43 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are able to understand and use the fluid management app.You need to have a smartphone and be comfortable using apps regularly.You have a smartphone that runs on either iOS or Android operating systems.You have severe heart failure, classified as Class III or IV.You are planning to receive a kidney transplant from a living donor in the next four months.
Research Study Groups:
This trial has the following groups:- Group 1: Vanguard
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger